Sector: Pharmaceuticals & Biotechnology

Small Cap

Bafna Pharma Share Price

BAFNAPH

₹204.61

4.01(2.00%)

10th Jul 2026 | 2:14 PM

NSE : BAFNAPH

Open Free Demat Account

Bafna Pharma Performance

Price Movement

₹204.61

₹200.65

₹204.61

↘ Today's Low↗ Today's High

1 Year Performance

₹204.61

₹78.18

₹227.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹204.61

Low₹200.65

Open at₹0.00

Prev Close₹200.60

Volumes2.35 K

Avg Price₹201.39

Lower Circuit₹196.59

Upper Circuit₹204.61

Historical Performance

3M High₹227.00

3M Low₹125.00

1 Yr High₹227.00

1 Yr Low₹78.18

3 Yr High₹227.00

3 Yr Low₹69.00

5 Yr High₹227.00

5 Yr Low₹69.00

Summary

As of 10-07-2026 23:15, Bafna Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-200.60 (-100.00%) from the previous close of ₹200.6. The stock opened at ₹0 and traded between ₹200.65 and ₹204.61, with a total traded volume of 2348 shares. The company has a market capitalization of ₹474.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹227 and ₹78.18, respectively.

Bafna Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 42.8, and book value of ₹4.90. Profitability indicators show ROE of 11.54%. Bafna Pharmaceuticals Ltd. has reported revenue of ₹150.62 Cr and net profit of ₹11.1 Cr.

Bafna Pharmaceuticals Ltd. technical indicators include Day RSI at 59.49, Day MFI at 68.12, Day ADX at 41.78. Additional indicators include Commodity Channel Index (CCI) at 42.5 and Williams %R at -36.16. Momentum indicators show Day MACD at 15.44, Day MACD Signal Line at 15.6, DayATR at 8.11. Rate of Change indicators for Bafna Pharmaceuticals Ltd. include ROC125 at 32.72 and ROC21 at 14.9.

Exponential moving averages include EMA5 at ₹206, EMA10 at ₹203.3, EMA12 at ₹201, EMA20 at ₹191.8, EMA26 at ₹185.6, EMA50 at ₹168.4, EMA100 at ₹152.2, EMA200 at ₹138.2. Simple moving averages include SMA5 at ₹208.2, SMA10 at ₹210.1, SMA20 at ₹187.4, SMA30 at ₹177.3, SMA50 at ₹160.1, SMA100 at ₹139.4, SMA150 at ₹138.6, SMA200 at ₹143.4.

Support levels for Bafna Pharma are placed at First Support ₹199.25, Second Support ₹197.90, Third Support ₹195.50. Resistance levels are seen at First Resistance ₹203.00, Second Resistance ₹205.40, Third Resistance ₹206.75. Bafna Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 9.34%, DII holding at 0%, public holding at 15.66%.

Bafna Pharma Fundamentals

Market Cap

Above industry Median

474.50 Cr.

PE Ratio (TTM)

Above industry Median

42.80

Dividend Yield

Net Profit TTM

167.5% incr over last year

11.10

Net Profit Growth

167.5% incr over last year

11.10

PEG Ratio

Above industry Median

0.30

ROE

136.0% incr over last year

11.54

Operating Revenue TTM

150.62

Operating Revenue Growth

3.3% incr over last year

Book Value

Above industry Median

4.90

MFI

MFI is mid-range

68.12

RSI

RSI is mid-range

59.49

EPS (TTM)

-15.52

Debt to Equity

-0.71

Face Value

Operating Profit Margin Qtr.

2.86

Operating Profit Qtr.

4.24

Net Profit Qtr.

0.32

Operating Revenue Qtr.

13.13

PB Ratio

4.90

Bafna Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	42.24	38.29	35.47	34.62	39.06
Operating Expense	38.69	35.24	31.19	29.56	35.95
Operating Profit	3.55	3.05	4.28	5.07	3.11
Depreciation	1.66	1.57	1.47	1.37	0.22
Interest	1.03	0.86	0.86	0.91	0.82
Tax	-0.13	0	0	0	0
Net Profit	2.75	1.84	3.12	3.39	1.31

Bafna Pharma Technicals

Bafna Pharmaceuticals Ltd. EMA & SMA

₹204.61

0.56 (0.27%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹206

Day EMA10 ₹203.3

Day EMA12 ₹201

Day EMA20 ₹191.8

Day EMA26 ₹185.6

Day EMA50 ₹168.4

Day EMA100 ₹152.2

Day EMA200 ₹138.2

Bafna Pharma Support and Resistance

Resistance

First Resistance₹203.00

Second Resistance₹205.40

Third Resistance₹206.75

Support

First Support₹199.25

Second Support₹197.90

Third Support₹195.50

Technical Indicators

Day RSI59.49

Day MFI68.12

Day ADX41.78

Day Commodity Channel Index42.50

William-36.16

Day MACD15.44

Day MACD Signal Line15.60

Day ATR8.11

Day ROC12532.72

Day ROC2114.90

Bafna Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	88.3	75	75	75	75	75
FII	0	8.5	9.3	9.3	9.3	9.3
DII	0	0	0	0	0	0
Public	11.7	16.5	15.7	15.7	15.7	15.7

Bafna Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	5.35 K	5.35 K	100.00%
Week	9.4 K	9.4 K	100.00%
1 Month	34.54 K	34.54 K	100.00%
6 Month	10.84 K	12.68 K	85.50%

Bafna Pharma SWOT Analysis

Strengths19

Weakness6

Opportunity0

Threats0

High DVM Mid and Small Caps (subscription)

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Bafna Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep, 2013	0.6	FINAL		Equity Share

Bafna Pharma Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹587.60	₹5.40	₹179.17	₹15.60	₹535	₹62
% Change	-1.43%	-0.18%	-2.00%	0.84%	-0.10%	-0.26%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	₹176.50	₹502.55	₹237.47
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	₹27.81	₹57.92	₹-3.28
PE TTM	-	-1.30	47.70	29.60	26.70	-103.00
1 Year Return	52.07	441	45.1	70	-25.38	-41.91
ROCE	3.56	-5.63	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 22.67

+1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+0.50%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.80

+0.43%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 568.90

+0.36%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.62

-1.99%

MEDICO

Medico Remedies Ltd.

₹ 39.10

+0.03%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 195.49

+1.38%

LASA

Lasa Supergenerics Ltd.

₹ 7.52

+1.21%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 330.00

+1.74%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 345.50

-1.31%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.50

+1.10%

BROOKS

Brooks Laboratories Ltd.

₹ 69.90

-0.87%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2861.10

+7.69%

ALPA

Alpa Laboratories Ltd.

₹ 68.70

+0.60%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 403.00

-0.99%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.21

-0.18%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.75

+1.80%

INDOCO

Indoco Remedies Ltd.

₹ 259.00

+1.53%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 247.05

+4.87%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 612.00

+0.01%

PANACEABIO

Panacea Biotec Ltd.

₹ 546.00

-1.66%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 244.00

-0.57%

THEMISMED

Themis Medicare Ltd.

₹ 117.59

+1.33%

FAQ's on BAFNAPH

What is the current share price of Bafna Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Bafna Pharmaceuticals Ltd. is ₹ 204.61 on the NSE and ₹ 207.55 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Bafna Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Bafna Pharmaceuticals Ltd. is approximately ₹ 474.5 Cr.

What are the PE and PB ratios for Bafna Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Bafna Pharmaceuticals Ltd. is 42.8, and the Price-to-Book (PB) ratio is 4.9.

What is the 52-Week High and Low for Bafna Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Bafna Pharmaceuticals Ltd. shares was ₹ 227, and the lowest price was ₹ 78.18.

Who are the major shareholders of Bafna Pharmaceuticals Ltd.?

Significant shareholdings in Bafna Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Bafna Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Bafna Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 0.6 per share for the financial period ending 2013. The record date was set as 2013-09-19, and the payment was/is scheduled around 2013-09-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy